# Sirius Medical Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sirius-medical-systems-b-v

- Industry: Medical Devices & Equipment
- Headquarters: Eindhoven, Netherlands
- Website: www.sirius-medical.com
- Total disclosed funding: $18M
- Latest round: Series B (Mar 21, 2023)
- Investors on record: 7

## About

Based in Eindhoven, Netherlands, and founded in 2017 by CEO/CTO Bram Schermers and Hubert Martens, Sirius Medical Systems B.V. is a spin-off from the Netherlands Cancer Institute, developing medical devices for oncological surgery. In February 2025, Sirius Medical Systems B.V. raised EUR 10 million in growth funding led by new investor NextGen Ventures, with participation from another new investor De Groot Family Office. Returning investors BOM Brabant Ventures, Holland Capital, Curie Capital, Team Holmium, and other unspecified investors also participated in the round. Sirius Medical provides Sirius Pintuition System powered by GPSDetect software that enables breast surgeons to accurately pinpoint the tumor location during surgery while optimizing hospital workflow. The company will use the funding to further develop its software platform, GPSDetect, and Sirius Pintuition system.

## Funding rounds

- Series B, Mar 21, 2023, $13M — Holland Capital, Hayfin Capital Management, BOM Brabant Ventures, Curie Capital, Team Holmium
- Series A, Dec 14, 2021 — Holland Capital, BOM Brabant Ventures, Curie Capital
- Series A, Jul 13, 2020, $5M — Holland Capital, BOM Brabant Ventures, Curie Capital, Dutch Research Council, Mibiton Foundation

## Investors

- Holland Capital (https://capitalatlas.ai/funds/holland-capital) — Series A, Series B
- BOM Brabant Ventures (https://capitalatlas.ai/funds/bom-brabant-ventures) — Series A, Series B
- Curie Capital (https://capitalatlas.ai/funds/curie-capital) — Series A, Series B
- Dutch Research Council — Series A
- Mibiton Foundation — Series A
- Hayfin Capital Management (https://capitalatlas.ai/funds/hayfin-capital-management) — Series B
- Team Holmium — Series B